Blockade of the VEGF pathway with mAbs
Blockade of the VEGF pathway with mAbs. The specificity of the VEGF family ligands for the VEGF receptors and coreceptors are shown. The clinically-relevant mAbs targeting the anti-VEGF pathway discussed in this review are placed based on their blockade of VEGF ligand or receptor. The ligand-binding antibodies bevacizumab (bev), r84, and VEGF-Trap inhibit ligand binding to the indicated receptor. IMC-18F1 and IMC-1121B bind VEGFR1 and VEGFR2 respectively, and prevent ligand binding.
Publication
The VEGF family in cancer and antibody-based strategies for their inhibition. (2010) Laura A Sullivan, et al. MAbs. 2010 Mar-Apr;2(2):165-175. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | VEGF-A | VEGFA | ncbigene_symbol | VEGFA | 7422 |
| Homo sapiens | Primates | VEGF-B | VEGFB | ncbigene_symbol | VEGFB | 7423 |
| Homo sapiens | Primates | VEGF-C | VEGFC | ncbigene_symbol | VEGFC | 7424 |
| Homo sapiens | Primates | PIGF | PIGF | ncbigene_symbol | PIGF | 5281 |
| Homo sapiens | Primates | PIGF | PIGF | ncbigene_synonym | PGF | 5228 |
| Homo sapiens | Primates | VEGF-D | VEGF-D | ncbigene_synonym | VEGFD | 2277 |
| Homo sapiens | Primates | Npn1,2 | NPN2 | ncbigene_synonym | NRP2 | 8828 |
| Homo sapiens | Primates | VEGFR1 | VEGFR1 | ncbigene_synonym | FLT1 | 2321 |
| Homo sapiens | Primates | VEGFR2 | VEGFR2 | ncbigene_synonym | KDR | 3791 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|